— Published date: 1/14/2026
Value Proposition: Method and composition to potently neutralize EEEV infection.
Technology Description
Researchers at Washington University in St. Louis have developed very low-density lipoprotein receptor (VLDLR) soluble decoy receptors with potent inhibitory acti…
— Published Date: 5/14/2025
Value proposition: Using CAR T-cells to treat Alzheimer’s disease and other neurodegenerative diseases through Ab-specific activation.
Technology Description
While CD4+ (helper or effector) T-cells play complex roles in the pathophysiology of Alzheimer’s …
— Published Date: 5/13/2025
Value proposition: New therapeutic modality that uses CNS self-peptides to treat autoimmune diseases, reducing neuroinflammation damage in an organ-specific manner.
Technology Description
Autoimmune diseases continue to debilitate countless individuals, increasing healt…
— Published Date: 5/13/2025
Value Proposition: Promotion of recovery and reduction of neuronal damage following nerve injury, first T cell approach to neurological disorders.
Technology Description
Traumatic injuries to the spinal cord or the brain currently have limited treatment options, particu…
— Published Date: 4/29/2025
Value Proposition: Novel biomarker that can be used as a diagnostic to identify glaucoma severity or progression in patients.
Technology Description
Researchers at Washington University in St. Louis have identified a novel biomarker, GDF15, for glaucoma that can detect …
| Name | # Summaries | Author |
|---|---|---|
| 15 | ||
| 13 | ||
| 15 | ||
| 26 | ||
| 14 | ||
| 14 |
Creating...
